肠道菌群在急性胰腺炎中作用的研究进展

Advances in the Role of Gut Microbiota in Acute Pancreatitis

  • 摘要: 急性胰腺炎(acute pancreatitis, AP)以胰腺腺泡细胞损伤为基本病理特征,引发全身炎症反应综合征和多器官功能障碍综合征,从而进展为重症急性胰腺炎(severe acute pancreatitis, SAP),病死率显著升高。肠道菌群作为机体最大的微生态系统,参与营养物质的分解和吸收,维持宿主的生理功能稳态,并在炎症反应中发挥重要作用。肠道菌群失调与AP通过多重机制相互影响,共同构成促进疾病进展的恶性循环。调节肠道菌群、恢复微生态平衡可有效调控炎症级联反应,有望降低SAP的发病率。本文就肠道菌群在急性胰腺炎疾病进程中的作用及治疗价值进行综述,以期为急性胰腺炎的治疗提供新思路。

     

    Abstract: Acute pancreatitis (AP) is characterized by injury of pancreatic acinar cells, triggering systemic inflammatory response syndrome and multiple organ dysfunction syndrome, and progressing to severe acute pancreatitis (SAP) with significantly increased mortality. As the largest micro-ecosystem in the body, the gut microbiota participates in the digestion and absorption of nutrients and maintains host physiological homeostasis, whilst also playing a pivotal role in inflammatory responses. Dysbiosis of the gut microbiota and AP interact through multiple mechanisms, forming a vicious cycle that promotes disease progression. Modulation of the gut microbiota and restoration of microbial ecological balance can effectively regulate inflammatory cascades, holding promise for reducing the incidence of SAP. This review summarizes the role of the gut microbiota in the disease course of AP and its therapeutic value, aiming to provide new insights into the treatment of acute pancreatitis.

     

/

返回文章
返回